ArticleModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2021

MHC class I loss in endometrial carcinoma: a potential resistance mechanism to immune checkpoint inhibition.

Lisa A Friedman et al.PubMed ↗Publisher ↗

No numbers read from the abstract.